Invitation to the presentation of ALK’s first six months (Q2) 2025 results on Thursday, 21 August 2025

Group 1 - ALK will publish its results for the first six months of 2025 on 21 August 2025, followed by a presentation for investors and analysts at 1:30 p.m. CEST [1] - The presentation will be available on ALK's website shortly before the meeting starts [4] - The meeting will be audio webcasted live and available for replay on ALK's website [2] Group 2 - Participants can join the conference call by registering through a provided link and will receive dial-in details via email [3] - ALK is a global specialty pharmaceutical company focused on allergy and allergic asthma, employing around 2,800 people worldwide [6] - The company is headquartered in Hørsholm, Denmark, and is listed on Nasdaq Copenhagen [6]